Biologics: targeting systemic inflammation in psoriasis

被引：2
|
作者：
Gjersvik, Petter [1 ,2 ]
机构：
[1] Univ Oslo, Inst Clin Med, Oslo, Norway
[2] Oslo Univ Hosp, Dept Dermatol, NO-0270 Oslo, Norway
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2018年 / 179卷 / 02期
关键词：
DISEASE;
D O I：
10.1111/bjd.16775
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：247 / 248
页数：2
相关论文
共 50 条
  • [41] Biologics in nail psoriasis
    de Berker, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02) : 236 - 237
  • [42] Biologics in the management of psoriasis
    Bahner, Jennifer D.
    Cao, Lauren Y.
    Korman, Neil J.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2009, 2 : 111 - 128
  • [43] THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES
    Mason, Kayleigh
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 33 - 33
  • [44] Systemic Therapies in Psoriasis: An Update on Newly Approved and Pipeline Biologics and Oral Treatments
    Havnaer, Annika
    Weinberg, Jeffrey M.
    Han, George
    CUTIS, 2019, 104 (02): : 17 - 20
  • [45] Systemic inflammation and evidence of a cardiosplenic axis in patients with psoriasis
    Hjuler, K. F.
    Gormsen, L. C.
    Vendelbo, M. H.
    Egeberg, A.
    Nielsen, J.
    Iversen, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E247 - E248
  • [46] Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis
    Sen, Bilge Bulbul
    Rifaioglu, Emine Nur
    Ekiz, Ozlem
    Inan, Mehmet Ugur
    Sen, Tugba
    Sen, Nihat
    CUTANEOUS AND OCULAR TOXICOLOGY, 2014, 33 (03) : 223 - 227
  • [47] Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis
    Akyurek, F.
    Akyurek, F. T.
    Abusoglu, S.
    Unlu, A.
    FEBS JOURNAL, 2015, 282 : 124 - 124
  • [48] The concept of psoriasis as a systemic inflammation: implications for disease management
    Reich, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 : 3 - 11
  • [49] Targeting systemic inflammation in atherosclerosis: Who will benefit?
    Good, Elin
    de Muinck, Ebo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (09) : 921 - 922
  • [50] DIFFERENTIAL PROTECTIVE EFFECTS OF BIOLOGICS AND METHOTREXATE ON VASCULAR INFLAMMATION AND THROMBOTIC RISK IN A MODEL OF PSORIASIS
    Andujar, I
    Garcia-Martinez, P.
    Collado-Diaz, V
    Mateu-Puchades, A.
    Alcon, N.
    Lopez-Fernandez, E.
    Blas-Garcia, A.
    Alvarez, A.
    Esplugues, J., V
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 45 - 46
12345